Status:

COMPLETED

Comparison Study of Daily Ultrafiltration and Twice-weekly Hemodialysis

Lead Sponsor:

Renal Research Institute

Collaborating Sponsors:

Vizio Medical Devices

Conditions:

End-stage Renal Disease

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

In this study, the researchers want to find out how patients who have ultrafiltration (removal of excess fluid) 6 times a week and twice-weekly dialysis (removal of excess fluid and waste products) do...

Eligibility Criteria

Inclusion

  • Age greater than or equal to 18 years and less than or equal to 80 years
  • Stable three treatments per week dialysis schedule for at least three months prior to beginning the study
  • Residual renal clearance \<1.5ml/min per 35L of urea volume
  • Pre-dialysis serum sodium levels of greater than 136 mEq/L

Exclusion

  • Non-compliance with hemodialysis treatments--defined as missing more than 1 treatment over the 3 month period prior to the study
  • Unable to verbally communicate in English or Spanish
  • Current requirement for hemodialysis more than three times per week due to medical comorbidity (including fourth session for ultrafiltration)
  • Currently on daily or nocturnal hemodialysis, or less than 3 months since discontinued such treatment
  • Expected geographic unavailability at dialysis center during any phase of the trial
  • Less than 3 months since the patient returned after acute rejection resulting in allograft failure
  • Currently in acute care or chronic care hospital
  • Pregnancy
  • Current involvement in any non-observational trial
  • Unable or unwilling to follow the study protocol for any reason (including mental incompetence)
  • Unable or unwilling to provide informed consent or sign IRB-approved consent form
  • Pace maker, implantable pump, artificial joint
  • Amputation of a limb

Key Trial Info

Start Date :

July 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2011

Estimated Enrollment :

13 Patients enrolled

Trial Details

Trial ID

NCT00825318

Start Date

July 1 2009

End Date

December 1 2011

Last Update

May 26 2014

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Irving Place Dialysis Center

New York, New York, United States, 10003

2

Upper Manhattan Dialysis Center

New York, New York, United States, 10025

3

Yorkville Dialysis Center

New York, New York, United States, 10128

Comparison Study of Daily Ultrafiltration and Twice-weekly Hemodialysis | DecenTrialz